Cargando…
An interaction between warfarin and cannabidiol, a case report
• An interaction between warfarin and cannabidiol is described; • The mechanisms of cannabidiol and warfarin metabolism are reviewed; • Mechanism of the interaction is proposed; • INR should be monitored in patients when cannabinoids are introduced;
Autores principales: | Grayson, Leslie, Vines, Brannon, Nichol, Kate, Szaflarski, Jerzy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789126/ https://www.ncbi.nlm.nih.gov/pubmed/29387536 http://dx.doi.org/10.1016/j.ebcr.2017.10.001 |
Ejemplares similares
-
Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program
por: Gaston, Tyler E., et al.
Publicado: (2023) -
A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy
por: Sharma, Ayushe A., et al.
Publicado: (2019) -
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
por: Davis, Brittney H., et al.
Publicado: (2021) -
Clinical implications of trials investigating drug‐drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs
por: Patsalos, Philip N., et al.
Publicado: (2020) -
The critical interaction between valproate sodium and warfarin: case report and review
por: Zhou, Chenguang, et al.
Publicado: (2018)